S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Avoro Capital Advisors/Q1 2022

Avoro Capital Advisors

Period: Q1 2022 Β· Filed: 2022-05-16
View on SEC EDGAR β†—
AUM
$5.48B
Total portfolio value
Positions
43
Reported securities
Top Holding
HZNP
12.5% $683.9M
QoQ Changes
+4 / -1
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2022-05-16) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
HZNPHORIZON THERAPEUTICS PLC$683.9M12.48%β€”β€”
12.5%
UTHRUNITED THERAPEUTICS CORP$543.6M9.92%$179.41$555.91+209.8%
9.9%
APLSAPELLIS PHARMACEUTICALS INC$480.2M8.77%$50.81β€”
8.8%
MRTXMIRATI THERAPEUTICS INC$437.8M7.99%β€”β€”
8.0%
ARGXARGENX SE$395.7M7.22%$315.31$939.68+198.0%
7.2%
XBISPDR SERIES TRUST - S&P BIOTECH$274.1M5.00%$89.31$160.46+79.7%
5.0%
ASNDASCENDIS PHARMA$258.2M4.71%$117.36$274.50+133.9%
4.7%
SRPTSAREPTA THERAPEUTICS INC$244.9M4.47%$78.12$19.28-75.3%
4.5%
BMRNBIOMARIN PHARMACEUTICAL INC$234.0M4.27%$77.10$58.99-23.5%
4.3%
ALNYALNYLAM PHARMACEUTICALS INC$212.3M3.88%$163.29$312.78+91.5%
3.9%
FOLDAMICUS THERAPEUTICS INC$194.1M3.54%β€”β€”
3.5%
SGENSEAGEN INC$189.4M3.46%β€”β€”
3.5%
XENEXENON PHARMACEUTICALS INC$152.4M2.78%$30.57$60.96+99.4%
2.8%
IOVAIOVANCE BIOTHERAPEUTICS INC$151.9M2.77%$16.65$4.31-74.1%
2.8%
MDGLMADRIGAL PHARMACEUTICALS INC$139.8M2.55%$98.12$528.10+438.2%
2.5%
ISEEIVERIC BIO INC$122.0M2.23%β€”β€”
2.2%
KURAKURA ONCOLOGY INC$77.2M1.41%$16.08$11.10-31.0%
1.4%
KRYSKRYSTAL BIOTECH INC$66.9M1.22%$66.54$375.07+463.7%
1.2%
ACADACADIA PHARMACEUTICALS INC$55.1M1.01%$24.22$25.97+7.2%
1.0%
GLUEMONTE ROSA THERAPEUTICS INC$46.4M0.85%$14.02$24.21+72.7%
0.8%
PMVPPMV PHARMACEUTICALS INC$45.8M0.84%$20.82$1.22-94.1%
0.8%
SNDXSYNDAX PHARMACEUTICALS INC$38.6M0.70%$17.38$21.82+25.6%
0.7%
DSGNDESIGN THERAPEUTICS INC$35.9M0.66%$16.15$15.64-3.2%
0.7%
KYMRKYMERA THERAPEUTICS INC$34.5M0.63%$42.32$113.51+168.2%
0.6%
MNKDMANNKIND CORP$32.4M0.59%$3.68$4.52+22.8%
0.6%
CBAYCYMABAY THERAPEUTICS INC$32.0M0.58%β€”β€”
0.6%
WHWKAADI BIOSCIENCES INC$31.0M0.57%$16.97$4.19-75.3%
0.6%
BCRXBIOCRYST PHARMACEUTICLAS INC$30.5M0.56%$16.26$9.84-39.5%
0.6%
MRNSMARINUS PHARMACEUTICALS INC$29.4M0.54%β€”β€”
0.5%
MRSNMERSANA THERAPEUTICS INC$27.1M0.50%β€”β€”
0.5%

Quarter-on-Quarter Activity

Q1 2022 vs. Q4 2021

New Positions (4)

TickerIssuerNotionalSince Filing
SGENSEAGEN INC$189.4M
BCRXBIOCRYST PHARMACEUTICLAS INC$30.5M-39.5%
RAREULTRAGENYX PHARMACEUTICAL INC$16.7M
AMTIAPPLIED MOLECULAR TRANS INC$7.8M

Exited Positions (1)

TickerIssuerNotional
ARNAARENA PHARMACEUTICALS INC$114.8M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
SRPTSAREPTA THERAPEUTICS INC$242.0M+945.0%-75.3%
XBISPDR SERIES TRUST - S&P BIOTECH$156.6M+190.5%+79.7%
KRYSKRYSTAL BIOTECH INC$33.6M+111.6%+463.7%
DICEDICE THERAPEUTICS INC$6.3M+91.1%
PMVPPMV PHARMACEUTICALS INC$12.0M+50.2%-94.1%
KYMRKYMERA THERAPEUTICS INC$-0.4M+48.5%+168.2%
DSGNDESIGN THERAPEUTICS INC$0.9M+35.8%-3.2%
ARGXARGENX SE$57.8M+30.1%+198.0%

Trimmed (4)

TickerIssuerNotionalShares Ξ”Since Filing
HZNPHORIZON THERAPEUTICS PLC$-317.8M-30.1%
NUVLNUVALENT INC$-3.9M-4.8%
MRNSMARINUS PHARMACEUTICALS INC$-9.0M-2.6%
UTHRUNITED THERAPEUTICS CORP$-112.2M-0.2%+209.8%
← Back to Hedge Funds